Efavirenz Comparative Bioavailability

PHASE4CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

June 30, 2013

Study Completion Date

August 31, 2013

Conditions
Healthy
Interventions
DRUG

Efavirenz 600 Test-Stocrin 600 Reference

DRUG

Stocrin 600 Reference-Efavirenz 600 Test

Trial Locations (1)

11600

Center for Cllinical Pharmacology Research-Bdbeq S.A., Montevideo

All Listed Sponsors
collaborator

University of the Republic, Uruguay

OTHER

lead

Center for Clinical Pharmacology Research Bdbeq S.A.

OTHER

NCT01704898 - Efavirenz Comparative Bioavailability | Biotech Hunter | Biotech Hunter